|
Baseline characteristics and quality of follow up in the two groups 1980–2005 |
||
| Turkish descent N (%) |
Not Turkish N (%) |
|
|
|
||
| Number of cases |
1774 |
35,485 |
|
|
||
| male sex |
1042 (58.7) |
19,822 (55.9) |
|
|
||
| Age at diagnosis |
||
| <1 year |
167 (9.4) |
3555 (10.0) |
| 1–<5 years |
682 (38.4) |
12,914 (36.4) |
| 5–<10 years |
503 (28.4) |
9516 (26.8) |
| 10–<15 years |
422 (23.8) |
9500 (26.8) |
|
|
||
| Year of diagnosis |
||
| 1980–87 |
369 (20.8) |
7576 (21.4) |
| 1988–95 |
477 (26.9) |
11,366 (32.0) |
| 1996–2005 |
928 (52.3) |
16,543 (46.6) |
|
|
||
| Median length of follow-up of patients still alive (range) in years |
7.1 (0–28) |
8.4 (0–28) |
|
|
||
| Deaths by 31.12.2006 |
456 (25.7) |
8737 (24.6) |
|
|
||
| Follow-up by period of diagnosis |
||
|
|
||
| 1980–1995 |
||
| Alive, at least 10 years f/u |
507 (92.0) |
12,613 (96.7) |
| Alive, lost to f/u |
93 (16.9) |
910 (7.0) |
|
|
||
| 1980–2000 |
||
| Alive, at least 5 years f/u |
879 (95.8) |
19,549 (98.5) |
| Alive, lost to f/u |
116 (12.6) |
1104 (5.6) |
|
|
||
| 1996–2000 |
||
| Alive, at least 5 years f/u |
357 (97.3) |
6725 (98.8) |
| Alive, lost to f/u |
23 (6.3) |
194 (2.9) |
|
N = number, f/u = follow-up | ||
Spix et al. BMC Cancer 2008 8:355 doi:10.1186/1471-2407-8-355 |
||